Resources – Concord Biotech commercialises Amphotericin B (API)

concord > News > Resources – Concord Biotech commercialises Amphotericin B (API)

A Knowledge Hub 

At Concord Biotech, we’re dedicated to empowering the professionals with the valuable insights needed to enhance patient care and drive innovation in healthcare. 

Concord Biotech in the News

Concord Biotech commercialises Amphotericin B (API)

Concord Biotech commercialises Amphotericin B (API).

Concord Biotech manufactures niche fermentation based Biotechnology company, manufacturing. API’s across various therapeutics segment like Immunosuppressants, Oncology, Anti-infective & antifungals and supplies to global pharmaceutical companies.

LINK: https://www.linkedin.com/posts/concord-biotech-limited_concordbiotech-pharma-healthcare-activity-6820358951478132736-ek4_?utm_source=linkedin_share&utm_medium=member_desktop_web

11